In an era where preventive healthcare is gaining momentum, microbiome science is emerging as a powerful frontier in personalizing wellness. MicrobioTx is at the forefront of this shift, leveraging AI-driven insights and India-specific data to make gut health solutions more precise, accessible, and impactful. In this exclusive conversation, Akanksha Gupta, Co-founder, MicrobioTx shares with Dr. Asawari Savant, Elets News Network (ENN), the vision behind transforming gut health into a cornerstone of everyday healthcare in India. Edited excerpts

What inspired you to start MicrobioTx, and what problem were you determined to solve in India’s healthcare landscape?

MicrobioTx was born from a clear gap between the latest research in microbiome science and its real-world adoption in an affordable, precise fashion. While global research says that gut microbiome is the foundation of preventive health, tests that measure the health of gut microbiome were too inconvenient or were too expensive for the average Indian.

We also looked at the current practice of generalisation in probiotics. Urban Indians suffer from gut-related issues, yet the market was flooded with “one-size-fits-all” probiotics. Our determination was to make this science personalised and targeted. By combining microbiome research with advanced AI, we set out to create affordable, data-driven gut health offerings making precise microbiome solutions inexpensive, convenient and real-time. We believe this will bridge the gap between the advancements in science and it’s real world adoption.

How do MicrobioTx’s hyper-personalized probiotics address individual health needs such as digestion, metabolism, immunity, and mental wellness?

At Microbiotx we believe your gut profile is as unique as your fingerprint, so your supplements should be too. Our Personal ProbioTx isn’t just a generic capsule, it is handcrafted by microbiologists based on the individual’s gut requirement.

We also have symptom specific probiotics for health needs as you have outlined. These probiotics have been made after extensive study of the Indian gut, and are scientifically/clinically proven. For example, MoodTx leverages the gut–brain axis, using psychobiotics to support mental wellness and help manage stress. We have seen substantial improvements in anxiety, depression and associated conditions with a month’s use.

India’s dietary diversity and lifestyle patterns are unique. How does MicrobioTx incorporate India-specific microbiome insights into its solutions?

Most global microbiome databases are built on Western food intake, which don’t reflect regionally diverse Indian palate. We’ve utilized data from Indian samples and our understanding of the Indian gut to integrate such India specific nuances in our solutions. Our AI models are trained specifically on these local population data, ensuring compatibility with the Indian biological context.

What recent innovations, partnerships, or product developments at MicrobioTx should the healthcare ecosystem watch for?

MicrobioTx is advancing preventive healthcare through data-driven gut science and hyper-personalized therapeutics. A significant innovation is our finger-prick–based Gut Function Test, which enables gut microbiome profiling using a few drops of blood, eliminating the need for stool samples and making microbiome insights more convenient. Complementing the test, we have recently introduced Personal ProbioTx, India’s first hyper-personalized probiotic formulation tailored to an individual’s microbiome profile, along with condition-specific formulations such as MoodTx, GlycoTx, LeanTx and DigesTx – targeting metabolic, mental wellness, weight management and digestive health needs.

We are driven to fast-track the adoption of personalized gut health solutions by collaborating with healthcare and wellness platforms – to broaden awareness and accessibility.  Looking ahead, the company is plans to extend microbiome-based interventions across multiple health conditions, positioning gut intelligence as a cornerstone of precision and preventive medicine.

Are you exploring collaborations with hospitals, wellness platforms, or digital health providers to integrate microbiome insights into mainstream care?

Absolutely. We see microbiome science as a collaborative tool, not a standalone product. We have partnered with multiple platforms, doctors and health providers to integrate gut health into corporate wellness ecosystems. Moving forward, we are deepening our ties with clinicians and hospitals. Our goal is for the Gut Function Test to become as standard as a routine lipid profile, helping doctors move from reactive treatment to proactive, microbiome-informed precision intervention.

What regulatory, ecosystem, or awareness-building measures are needed to accelerate adoption of microbiome-based preventive healthcare in India?

On the ecosystem side, we must bridge the “trust deficit.” This requires more India-centric clinical trials and peer-reviewed data to convince both the medical community and consumers that microbiome interventions are a science, not a lifestyle fad. Awareness needs to shift from “curing a stomach-upset” to “optimizing the microbiome for lifelong health.” From a regulatory perspective, having a clear framework and guidance for preventive solutions would accelerate the ease of adoption.

How do you see the market opportunity for microbiome-based diagnostics and personalized nutrition evolving in India over the next 3–5 years?

As the interest in microbiome diagnostics and therapies rises, we see microbiome based solutions driving the growth in wellness market.

In the next 3–5 years, we will see a shift from “generic wellness” to “precise wellness.” Consumers will no longer be happy with broad health claims; they will demand solutions tailored for their specific case. We also foresee microbiome testing becoming a core component of patient screening, particularly as the link between gut health and chronic conditions like diabetes and PCOS becomes more widely understood by the masses.

Also read: Step Into India’s Fastest-Growing Pharma Hub: The Biggest Pharma Exhibition in Hyderabad Awaits 

What is your long-term vision for MicrobioTx in advancing personalized and preventive healthcare?

Our vision is to translate today’s microbiome research into tomorrow’s clinical solutions. We aim to bring innovative, affordable and accessible microbiome-based solutions to unlock wellness from within.

We want MicrobioTx to be the engine behind a future where healthcare is no longer a “waiting game” for symptoms to appear, but a continuous journey of maintaining a healthy microbial balance to prevent diseases before they start.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Disclaimer: The views and opinions expressed in this article are solely those of the author and do not necessarily reflect the official policy or views of any organisation. The content is intended for informational and educational purposes only and should not be construed as medical advice.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!